Search
for
Sort by
Research 31–60 of 395
- Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
- Effects of mitotane treatment on human steroid metabolism: implications for patient management
- Docking-based workflow and ADME prediction of some compounds in Curcuma longa and Andrographis paniculata as polymerase PA-PB1 inhibitors of influenza A/H5N1 virus
- M2 Macrophage and Extracellular Matrix Genes Are Enriched in High‐Activity Lichen Planopilaris
- Teriflunomide in multiple sclerosis: an update
- Hair Loss Induced by Lopinavir-Ritonavir
- Treatment of Delusional Infestation with Olanzapine
- ラット精巣におけるビタミンD 代謝関連遺伝子の発現解析
- Particulate matter 2.5 damages skin cells by inducing oxidative stress, subcellular organelle dysfunction, and apoptosis
- Air Pollution, Autophagy, and Skin Aging: Impact of Particulate Matter (PM10) on Human Dermal Fibroblasts
- 910 Transepidermal UV radiation of human scalp skin induces distinctive hair follicle damage, which is mitigated by topical caffeine treatment
- The Rotterdam Study: 2016 objectives and design update
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Ritlecitinib: First Approval
- Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
- Red ginseng monograph
- Primary cicatricial alopecia
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Absorption sites of orally administered drugs in the small intestine
- Generation and characterization of rat liver stem cell lines and their engraftment in a rat model of liver failure
- Review of Fluconazole Properties and Analytical Methods for Its Determination
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Experimental and Clinical Pharmacology of<i>Ziziphus jujuba</i>Mills
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia